|
1
|
Ferlay J, Soerjomataram I, Dikshit R,
Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM,
Forman D and Bray F: Cancer incidence and mortality worldwide:
Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer.
136:E359–E386. 2015. View Article : Google Scholar
|
|
2
|
Herrero R, Park JY and Forman D: The fight
against gastric cancer - the IARC Working Group report. Best Pract
Res Clin Gastroenterol. 28:1107–1114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Proctor DM, Gatto NM, Hong SJ and
Allamneni KP: Mode-of-action framework for evaluating the relevance
of rodent forestomach tumors in cancer risk assessment. Toxicol
Sci. 98:313–326. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Phillips DH: Fifty years of
benzo(a)pyrene. Nature. 303:468–472. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Phillips DH: Polycyclic aromatic
hydrocarbons in the diet. Mutat Res. 443:139–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mastrangelo G, Fadda E and Marzia V:
Polycyclic aromatic hydrocarbons and cancer in man. Environ Health
Perspect. 104:1166–1170. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Labib S, Guo CH, Williams A, Yauk CL,
White PA and Halappanavar S: Toxicogenomic outcomes predictive of
fore-stomach carcinogenesis following exposure to benzo(a)pyrene:
Relevance to human cancer risk. Toxicol Appl Pharmacol.
273:269–280. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Benford D, Dinovi M and Setzer RW:
Application of the margin-of-exposure (MoE) approach to substances
in food that are genotoxic and carcinogenic e.g: benzo[a]pyrene and
polycyclic aromatic hydrocarbons. Food Chem Toxicol. 48(Suppl 1):
S42–S48. 2010. View Article : Google Scholar
|
|
9
|
IARC (International Agency for Research on
Cancer). Cadmium and cadmium compounds. IARC Monogr Eval Carcinog
Risks Hum. 58:119–237. 1993.PubMed/NCBI
|
|
10
|
Hattemer-Frey HA and Travis CC:
Benzo-a-pyrene: Environmental partitioning and human exposure.
Toxicol Ind Health. 7:141–157. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Srogi K: Monitoring of environmental
exposure to polycyclic aromatic hydrocarbons: A review. Environ
Chem Lett. 5:169–195. 2007. View Article : Google Scholar
|
|
12
|
Rubin H: Synergistic mechanisms in
carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco
smoke: A bio-historical perspective with updates. Carcinogenesis.
22:1903–1930. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lemieux CL, Douglas GR, Gingerich J,
Phonethepswath S, Torous DK, Dertinger SD, Phillips DH, Arlt VM and
White PA: Simultaneous measurement of benzo[a]pyrene-induced Pig-a
and lacZ mutations, micronuclei and DNA adducts in Muta™ Mouse.
Environ Mol Mutagen. 52:756–765. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Culp SJ, Gaylor DW, Sheldon WG, Goldstein
LS and Beland FA: A comparison of the tumors induced by coal tar
and benzo[a] pyrene in a 2-year bioassay. Carcinogenesis.
19:117–124. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wester PW, Muller JJ, Slob W, Mohn GR,
Dortant PM and Kroese ED: Carcinogenic activity of benzo[a]pyrene
in a 2 year oral study in Wistar rats. Food Chem Toxicol.
50:927–935. 2012. View Article : Google Scholar
|
|
16
|
Wang Q and Xue Y: Characterization of
solid tumors induced by polycyclic aromatic hydrocarbons in mice.
Med Sci Monit Basic Res. 21:81–85. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Denison MS, Soshilov AA, He G, DeGroot DE
and Zhao B: Exactly the same but different: promiscuity and
diversity in the molecular mechanisms of action of the aryl
hydrocarbon (dioxin) receptor. Toxicol Sci. 124:1–22. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hankinson O: Role of coactivators in
transcriptional activation by the aryl hydrocarbon receptor. Arch
Biochem Biophys. 433:379–386. 2005. View Article : Google Scholar
|
|
19
|
Probst MR, Reisz-Porszasz S, Agbunag RV,
Ong MS and Hankinson O: Role of the aryl hydrocarbon receptor
nuclear translocator protein in aryl hydrocarbon (dioxin) receptor
action. Mol Pharmacol. 44:511–518. 1993.PubMed/NCBI
|
|
20
|
Bersten DC, Sullivan AE, Peet DJ and
Whitelaw ML: bHLH-PAS proteins in cancer. Nat Rev Cancer.
13:827–841. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barouki R, Coumoul X and
Fernandez-Salguero PM: The aryl hydrocarbon receptor, more than a
xenobiotic-interacting protein. FEBS Lett. 581:3608–3615. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Safe S, Lee SO and Jin UH: Role of the
aryl hydrocarbon receptor in carcinogenesis and potential as a drug
target. Toxicol Sci. 135:1–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma Q and Whitlock JP Jr: The aromatic
hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and
differentiated state independently of dioxin. Mol Cell Biol.
16:2144–2150. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Portal-Nuñez S, Shankavaram UT, Rao M,
Datrice N, Atay S, Aparicio M, Camphausen KA, Fernández-Salguero
PM, Chang H, Lin P, et al: Aryl hydrocarbon receptor-induced
adrenomedullin mediates cigarette smoke carcinogenicity in humans
and mice. Cancer Res. 72:5790–5800. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Andersson P, McGuire J, Rubio C, Gradin K,
Whitelaw ML, Pettersson S, Hanberg A and Poellinger L: A
constitutively active dioxin/aryl hydrocarbon receptor induces
stomach tumors. Proc Natl Acad Sci USA. 99:9990–9995. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kawajiri K, Kobayashi Y, Ohtake F, Ikuta
T, Matsushima Y, Mimura J, Pettersson S, Pollenz RS, Sakaki T,
Hirokawa T, et al: Aryl hydrocarbon receptor suppresses intestinal
carcinogenesis in ApcMin/+ mice with natural ligands. Proc Natl
Acad Sci USA. 106:13481–13486. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Reddy KB, Nabha SM and Atanaskova N: Role
of MAP kinase in tumor progression and invasion. Cancer Metastasis
Rev. 22:395–403. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo J, Xu Y, Ji W, Song L, Dai C and Zhan
L: Effects of exposure to benzo[a]pyrene on metastasis of breast
cancer are mediated through ROS-ERK-MMP9 axis signaling. Toxicol
Lett. 234:201–210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie G, Peng Z and Raufman JP: Src-mediated
aryl hydrocarbon and epidermal growth factor receptor cross talk
stimulates colon cancer cell proliferation. Am J Physiol
Gastrointest Liver Physiol. 302:G1006–G1015. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gibbs GW, Labreche F, Busque MA and Duguay
P: Mortality and cancer incidence in aluminum smelter workers: A
5-year update. J Occup Environ Med. 56:739–764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang L and Li Y, Qiao L, Zhao Y, Wei Y
and Li Y: Protective effects of hepatic stellate cells against
cisplatin-induced apoptosis in human hepatoma G2 cells. Int J
Oncol. 47:632–640. 2015.PubMed/NCBI
|
|
32
|
Winnard PT Jr, Pathak AP, Dhara S, Cho SY,
Raman V and Pomper MG: Molecular imaging of metastatic potential. J
Nucl Med. 49(Suppl 2): S96–S112. 2008. View Article : Google Scholar
|
|
33
|
Saito H, Osaki T, Murakami D, Sakamoto T,
Kanaji S, Oro S, Tatebe S, Tsujitani S and Ikeguchi M: Macroscopic
tumor size as a simple prognostic indicator in patients with
gastric cancer. Am J Surg. 192:296–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Talamonti MS, Kim SP, Yao KA, Wayne JD,
Feinglass J, Bennett CL and Rao S: Surgical outcomes of patients
with gastric carcinoma: The importance of primary tumor location
and microvessel invasion. Surgery. 134:720–727; discussion 727–729.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gabay M, Li Y and Felsher DW: MYC
activation is a hallmark of cancer initiation and maintenance. Cold
Spring Harb Perspect Med. 4:42014. View Article : Google Scholar
|
|
37
|
Felsher DW: Cancer revoked: Oncogenes as
therapeutic targets. Nat Rev Cancer. 3:375–380. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
van Riggelen J, Yetil A and Felsher DW:
MYC as a regulator of ribosome biogenesis and protein synthesis.
Nat Rev Cancer. 10:301–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dang CV: MYC on the path to cancer. Cell.
149:22–35. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dang CV: c-Myc target genes involved in
cell growth, apoptosis, and metabolism. Mol Cell Biol. 19:1–11.
1999. View Article : Google Scholar
|
|
41
|
Zhang EB, Han L, Yin DD, Kong R, De W and
Chen J: c-Myc-induced, long, noncoding H19 affects cell
proliferation and predicts a poor prognosis in patients with
gastric cancer. Med Oncol. 31:9142014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Peng TL, Chen J, Mao W, Song X and Chen
MH: Aryl hydrocarbon receptor pathway activation enhances gastric
cancer cell invasiveness likely through a c-Jun-dependent induction
of matrix metalloproteinase-9. BMC Cell Biol. 10:272009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Okey AB: An aryl hydrocarbon receptor
odyssey to the shores of toxicology: The Deichmann Lecture,
International Congress of Toxicology-XI. Toxicol Sci. 98:5–38.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yin XF, Chen J, Mao W, Wang YH and Chen
MH: A selective aryl hydrocarbon receptor modulator
3,3′-Diindolylmethane inhibits gastric cancer cell growth. J Exp
Clin Cancer Res. 46:2012.
|
|
45
|
Li HJ, Che XM, Zhao W, He SC, Zhang ZL,
Chen R, Fan L and Jia ZL: Diet-induced obesity promotes murine
gastric cancer growth through a nampt/sirt1/c-myc positive feedback
loop. Oncol Rep. 30:2153–2160. 2013.PubMed/NCBI
|
|
46
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang BG, Du T, Zang MD, Chang Q, Fan ZY,
Li JF, Yu BQ, Su LP, Li C, Yan C, et al: Androgen receptor promotes
gastric cancer cell migration and invasion via AKT-phosphorylation
dependent upregulation of matrix metalloproteinase 9. Oncotarget.
5:10584–10595. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Parsons SL, Watson SA, Collins HM, Griffin
NR, Clarke PA and Steele RJ: Gelatinase (MMP-2 and -9) expression
in gastrointestinal malignancy. Br J Cancer. 78:1495–1502. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lai DW, Liu SH, Karlsson AI, Lee WJ, Wang
KB, Chen YC, Shen CC, Wu SM, Liu CY, Tien HR, et al: The novel Aryl
hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor
growth and peritoneal dissemination. Oncotarget. 5:7788–7804. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Peng TL, Chen J, Mao W, Liu X, Tao Y, Chen
LZ and Chen MH: Potential therapeutic significance of increased
expression of aryl hydrocarbon receptor in human gastric cancer.
World J Gastroenterol. 15:1719–1729. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yin XF, Chen J, Mao W, Wang YH and Chen
MH: Downregulation of aryl hydrocarbon receptor expression
decreases gastric cancer cell growth and invasion. Oncol Rep.
30:364–370. 2013.PubMed/NCBI
|
|
52
|
Qian J, Kong X, Deng N, Tan P, Chen H,
Wang J, Li Z, Hu Y, Zou W, Xu J, et al: OCT1 is a determinant of
synbindin-related ERK signalling with independent prognostic
significance in gastric cancer. Gut. 64:37–48. 2015. View Article : Google Scholar :
|
|
53
|
Xu X, Liu Z, Fang M, Yu H, Liang X, Li X,
Liu X, Chen C and Jia J: Helicobacter pylori CagA induces ornithine
decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway:
Implication for progression of gastric diseases. Exp Biol Med
(Maywood). 237:435–441. 2012. View Article : Google Scholar
|
